NOVARTIS VENTURE FUND
Our primary focus is on the development of novel therapeutics and platforms. We balance the therapeutic focus with investments in medical devices, diagnostics or drug delivery systems. In our investments we look for unmet need and clinical impact, novel proprietary science and understanding of mechanism, management and board experience and capital efficiency in the program. We prefer to have our initial investment at the early stage to build the company and follow with additional investment ... in pace with the company:tm:s progress. We continue our approach of larger focused investments and anticipate total investments up to USD 30 to 50 mio per company over its life, but it can be as little as 100'000 USD to get started. We will increase our activities to lead or co-lead deals further and remain open to participate in larger syndicates. Sectors New therapeutics & platforms Medical devices/implants Diagnostics/biomarkers Drug delivery/biopolymers Geography USA/Canada Europe Switzerland Asia/Pacific
NOVARTIS VENTURE FUND
Industry:
Finance Therapeutics Venture Capital
Founded:
1996-01-01
Status:
Active
Contact:
877 280 2296
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Google Universal Analytics DigiCert SSL GlobalSign Domain Verification Proofpoint Imperva Bot Detection And Mitigation
Similar Organizations
ABB Technology Ventures
ABB Technology Ventures (ATV) is the strategic venture capital unit of ABB (NYSE: ABB).
ALSA Ventures
ALSA Ventures invest in biotechnology companies passionate about bringing novel therapies to patients.
BB Biotech Ventures
BB BIOTECH VENTURES is a healthcare-dedicated venture capital fund, focused on companies that develop and market drugs and medical devices.
Civilization Ventures
Civilization Ventures is a venture capital firm focused on cutting edge innovations in exponential health tech and biology.
Claris Ventures
Claris Ventures is a venture capital firm focused on early-stage investments in high potential biopharma companies.
Digitalis Ventures
Digitalis is a venture capital firm that that invests in solutions to complex problems in human and animal health.
EIR Ventures
EIR Ventures is a new Life Science Venture Group in the Nordics.
Forward Ventures
Forward Ventures ic a venture capital company that focuses in companies in the area of biological sciences.
Founders Fund
Founders Fund is a venture capital firm investing in companies building revolutionary technologies.
Hikma Ventures
Hikma Ventures operates as the corporate venture capital arm of Hikma Pharmaceuticals.
Kibo Ventures
Kibo Ventures is a venture capital fund investing in early-stage internet and mobile companies.
LocalGlobe
LocalGlobe is a venture capital firm that focuses on seed and impact investments.
Novalis LifeSciences
Novalis Lifesciences is a globally acting venture capital firm focused on breakthrough technologies in Life Science.
Roche Venture Fund
The Roche Venture Fund is the name given to the corporate venture fund of the healthcare company Roche.
Samsung Ventures
Samsung Ventures is a venture capital firm specializing in investments in start-up companies.
TA Ventures
TA Ventures is a VC firm backing ambitious founders of technology companies across Europe, North America and beyond.
Union Square Ventures
Union Square Ventures is a venture capital firm that focuses on early-stage, growth-capital, late-stage, and startup financing.
VentureFriends
VentureFriends is a venture capital fund that invests in tech-enabled companies.
Current Advisors List
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-03-02 | Epsilogen | Novartis Venture Fund investment in Series B - Epsilogen | 30.75 M GBP |
| 2022-02-15 | Splice Bio | Novartis Venture Fund investment in Series A - Splice Bio | 50 M EUR |
| 2022-01-20 | ImmPACT Bio | Novartis Venture Fund investment in Series B - ImmPACT Bio | 111 M USD |
| 2021-12-28 | IKAS Industrial Automation | Novartis Venture Fund investment in Series B - IKAS Industrial Automation | 100 M CNY |
| 2021-12-16 | Anaveon | Novartis Venture Fund investment in Series B - Anaveon | 110 M CHF |
| 2021-11-23 | LOQUS23 THERAPEUTICS | Novartis Venture Fund investment in Seed Round - LOQUS23 THERAPEUTICS | 7 M GBP |
| 2021-11-15 | Kedalion Therapeutics | Novartis Venture Fund investment in Series B - Kedalion Therapeutics | N/A |
| 2021-10-05 | Exo Therapeutics | Novartis Venture Fund investment in Series B - Exo Therapeutics | 78 M USD |
| 2021-09-29 | Expansion Therapeutics | Novartis Venture Fund investment in Series B - Expansion Therapeutics | 80 M USD |
| 2021-09-15 | Flywheel.io | Novartis Venture Fund investment in Series C - Flywheel.io | 22 M USD |
More informations about "Novartis Venture Fund"
Biopharma/Biotech Investment | Novartis Venture Fund
The Novartis Venture Fund team’s approach to investing We prefer an active, hands-on style of investment, one major element of which involves taking a seat on the company board. This …See details»
Novartis Venture Fund Team - nvfund.com
The Novartis Venture Fund Team is made up of people with proven expertise and talent in bringing exciting new drugs and treatments to patients all over the world. Drawing on …See details»
Novartis Venture Fund - Crunchbase Investor Profile
Novartis Venture Fund prefers to have their initial investment at the early stage to build the company and follow with additional investment in pace with the company's progress. Their approach involves larger focused investments, with …See details»
Novartis Venture Fund - Investments, Portfolio & Company Exits
Sep 9, 2020 Novartis Venture Fund is a venture capital firm focused on companies that develop novel therapeutics and platforms. ... Novartis Venture Fund has made 41 diversity …See details»
Novartis Venture Fund (NVF) - Life-Sciences-Europe.com
Jan 1, 1996 Novartis (Group) Industry: venture capital : Industry 2: LIFE SCIENCES: Person: Murray, Campbell (Novartis 201203 Managing Director of Novartis Venture Fund) Person 2: …See details»
Novartis Venture Fund - Private Equity International
Novartis Venture Fund News, insights, analysis and data Founded in 1996, Novartis Venture Fund is a Switzerland based investment organisation that focuses on the healthcare sector, …See details»
Novartis Venture Fund Portfolio Companies - Crunchbase
Novartis Venture Fund is a venture capital firm focused on companies that develop novel therapeutics and platforms. This list of organizations invested in by Novartis Venture Fund …See details»
Novartis Venture Fund - StartupHub.ai
Jan 9, 1996 Investments by the Novartis Venture Fund are made as equity participation typically as the lead or co-lead investor in a syndicate with a board seat. Date Founded: January 9, …See details»
Our pharma portfolio strategy | Novartis Venture Fund
The Novartis Venture Fund currently invests in over 40 life science companies across North America and Europe with approximately USD 750 million under management. Our investment …See details»
Novartis Venture Fund - Base Templates Investor Profile
Novartis Venture Fund is a venture capital firm focused on companies that develop novel therapeutics and platforms. About this investor. Description. Novartis Venture Fund is a venture capital firm focused on companies that …See details»
Novartis Venture Fund - EU-Startups
Novartis Venture Fund’s primary focus is on the development of novel therapeutics and platforms. They balance the therapeutic focus with investments in medical devices, diagnostics, or drug …See details»
Novartis Venture Fund - Org Chart, Teams, Culture & Jobs - The Org
Novartis Venture Fund's primary focus is on the development of novel therapeutics and platforms. In their investments, they look for unmet need and clinical impact, novel proprietary science, …See details»
Novartis Venture Fund - Funding, Financials, Valuation & Investors
Novartis Venture Fund is a venture capital firm focused on companies that develop novel therapeutics and platforms. Search Crunchbase. Start Free Trial . Chrome Extension. …See details»
Meet Aaron Nelson | Novartis Venture Fund - nvfund.com
Prior to NVF, he was an investor at dRx Capital, a joint investment company of Novartis and Qualcomm, focused on Digital Medicine. Previously, Aaron worked on technology strategy …See details»
Novartis Venture Fund - GrantStation
The focus of the Novartis Venture Fund is on the development of novel therapeutics and platforms. The Fund makes equity investments in biotechnology and biopharma life sciences …See details»
Novartis Venture Fund: Valuation Dilemmas - The Case Centre
The Novartis Venture Fund (NVF) is considering investing in a start-up, Genedata, and must take into account the valuation analysis by both the start-up as well as Venture Valuation - an …See details»
Our Successes | Novartis Venture Fund - nvfund.com
The Novartis Venture Fund has invested in 67 life science companies so far, guiding them all to a mix of IPOs, mergers and acquisitions, and FDA drug approvals. The Novartis Venture Fund …See details»
Broader population could benefit from Novartis spinal muscular …
4 days ago With FDA approval, Novartis’ gene transfer therapy would be made available to type II SMA patients under 18 years of age, representing a much broader patient population. Key …See details»
Novartis Venture Fund - Contacts, Employees, Board Members
Novartis Venture Fund is a venture capital firm focused on companies that develop novel therapeutics and platforms. Search Crunchbase. Start Free Trial . Chrome Extension. …See details»
Lead Legal Counsel, Business Development & Licensing - Novartis
1 day ago Location: This role can be located in East Hanover, NJ or Cambridge, MA US. LI-#hybrid The Novartis Legal Transactions team is seeking an experienced transactional …See details»